NJII and Cognome Partner to Advance AI-Powered Health Care Solutions
New Jersey Innovation Institute (NJII), and Cognome are pleased to announce a strategic partnership to transform patient care with AI and ML solutions. This partnership leverages Cognome's ethical AI tools, developed at two leading academic health care systems, with NJII's professional services to deliver next-generation clinical intelligence, operational efficiencies and outcomes improvement.
Healthcare Innovation Solutions (HCIS), the Quality and Performance Improvement subsidiary of NJII, will play a key role in bringing these innovative and cutting-edge AI solutions to the marketplace.
"We are thrilled to partner with Cognome to advance AI and Machine Learning in health care," says Jennifer D'Angelo, NJII's COO and CEO of HCIS. "By aligning stakeholder initiatives, we can ensure all hospitals and providers benefit from AI-driven innovation, enhancing research, patient care, safety and operations."
NJII, an NJIT corporation, is dedicated to accelerating health care technology and fostering innovation throughout New Jersey and beyond. Cognome, formed through a joint venture between Montefiore Health System and the University of Texas at Houston, offers advanced AI and Machine Learning models, as well as the first-of-its-kind AI Governance platform, ExplainerAITM, purpose-built for health care. For over a decade, NJII has been a trusted leader in health care technology, data interoperability, and care transformation. NJII aims to drive AI adoption starting with proper governance, model implementation and co-development with our health care partners.
"This partnership aligns with our commitment to accelerate innovation in key sectors such as health care," says Tom Villani, PhD, NJII's VP of AI and Machine Learning. "All of our AI models integrate seamlessly with EHRs, delivering real-time insights to physicians. The Sepsis reduction model has demonstrated the lowest flag rate in the industry. AutoChart AI reduces manual chart abstraction by over 90%, providing significant ROI through operational efficiencies and prospective attribution."
The ExplainerAI™ platform, built on the NIH AI Governance framework, enhances trustworthiness and transparency while reducing bias through responsible AI models—crucial for clinician adoption. It also aligns with NIST's AI Risk Management Framework addressing the need for proper privacy, auditability, cybersecurity and compliance for AI models including those from third parties."
"Partnering with NJII combines our 15 years of building proven AI and ML capabilities with their deep knowledge and collaboration throughout NJ's health care ecosystem," says James Green, Cognome's CEO. "Size and diversity in patient data are the 'fuel' for intelligent, accurate, and responsible AI models."
The partnership will bring together health care delivery stakeholders including researchers, technology leaders, AI/ML practitioners as well as operational and quality teams to collaborate on high-value use cases. NJII will also provide data science expertise and custom model development services to meet the growing demand for advanced analytics and purpose-built AI solutions.
To learn more about this partnership, focused on delivering high-value operational and clinical use cases, join our upcoming webinar: "Accelerating AI Adoption in NJ Healthcare: Collaboration & Real-World Impact" on April 29 at 12 p.m. EDT. Register here.
For more information, visit:
NJII – New Jersey Innovation Institute
HCIS - Healthcare Innovation Solutions, Inc.
Cognome - AI-Powered Healthcare and Clinical Decision-Making | Cognome
